Active Pharmaceutical Ingredients - Dr Reddy's
Active Pharmaceutical Ingredients - Dr Reddy's

About Doxazosin Mesylate API

Product
  • Therapeutic Category Cardiovascular

  • CAS Number

    77883-43-3

  • API Technology

    High Potent

  • Dose Form

    Tablets

  • Dr Reddy's Development Status

    Under Development

  • Available Regulatory Filing

    USDMF, CEP Submitted, Brazil DMF

Mechanism of Action

Doxazosin is a quinazoline derivative that acts as a competitive alpha1-antagonist at the post-synaptic receptor. Doxazosin competitively inhibits post-synaptic alpha1-adrenergic receptors causing vasodilation of arterioles and veins, which results in decreased total peripheral resistance and blood pressure

Indication

Doxazosin belongs to a group of medicines called alpha blockers. It's used to treat high blood pressure (hypertension) and symptoms of an enlarged prostate (benign prostatic enlargement).

Request for Quotation

Get in touch with us by filling out the form below. Our team will reach out to you shortly!

Phone
Country *
Doxazosin Mesylate
Select Regulatory Requirements
Select Purpose

Related APIs

Clopidogrel Bisulfate (Form 1)

Cardiovascular

arrow

Dabigatran Etexilate Mesylate

Cardiovascular

arrow

Doxazosin Mesylate

Cardiovascular

arrow

Ezetimibe

Cardiovascular

arrow

Fondaparinux Sodium

Cardiovascular

arrow

Lacidipine

Cardiovascular

arrow

Tafamidis Free Acid

Cardiovascular

arrow

Clopidogrel Bisulfate (Form 2)

Cardiovascular

arrow

Metoprolol Succinate

Cardiovascular

arrow

Losartan Potassium

Cardiovascular

arrow

Atorvastatin Calcium (Form 1)

Cardiovascular

arrow

Acoramidis

Cardiovascular

arrow

Enalapril Maleate

Cardiovascular

arrow

Edoxaban

Cardiovascular

arrow

Amlodipine Besylate

Cardiovascular

arrow

Apixaban

Cardiovascular

arrow

Atorvastatin Calcium (Amorphous & Form 1)

Cardiovascular

arrow

Valsartan

Cardiovascular

arrow

Treprostinil

Cardiovascular

arrow

Ticagrelor

Cardiovascular

arrow

Bempedoic Acid

Cardiovascular

arrow

Sacubitril-Valsartan

Cardiovascular

arrow

Rivaroxaban

Cardiovascular

arrow

Ramipril

Cardiovascular

arrow
Disclaimer: Products under patent(s) are offered only for R&D purposes U/S 107A of the Patent Act (Bolar Exemption) and not for commercial sale.